Drug Shortage Information

New Updates on Hematologic Drug Shortages (updated: 04/25/2013)

  • New national shortage of the IV version of Aminocaproic Acid (Amicar), there are adequate supplies of the oral version.  Hospira is currently the only manufacturer of this therapy and the company is experiencing capacity constraints.  Hospira anticipates that Aminocaproic Acid product:  250 mg/mL; 20 mL vial (NDC 0409-4346-73) will be available via the normal distribution channels in mid-May.  Tranexamic Acid, an alternate to Aminocaproic Acid, is currently available through several manufacturers (including: APP Pharmaceuticals, Luitpold Pharmaceuticals, and Mylan Pharmaceuticals).  

Status of Current Hematologic Drug Shortages

Drug Name  Company
Information
 
Reason for Shortage/Availability  Related Information 

Acyclovir Sodium Injection

Updated: 01/17/2013

APP
Customer Service
1-888-386-1300
Manufacturing delays, Increased demand

All presentations currently on allocation with manufacturer. 

Next delivery expected early February 2013

Amikacin Injection

Updated: 01/18/2013

Teva Pharmaceuticals
1-800-545-8800
Demand increase for the drug.

Teva has 4mL vials available on allocation.

Teva expects to continue to allocate the product through January 2013. 

Bedford Customer Service
1-800-562-4797
Discontinuation of the manufacture of the drug. Unavailable.

Aminocaproic Acid (Amicar)

Updated: 04/25/2013

Hospira, Inc. Customer Service: 1-877-946-7747

Capacity constraints Next delivery May
Estimated recovery: 2Q 2013

Cytarabine injection (powder for reconstitution)

Updated: 07/12/2012

Bedford Customer Service
1-800-562-4797
100 mg vial (NDC 55390-0131-10)
500 mg vial (NDC 55390-0132-10)
1 gram vial (NDC 55390-0133-01)
2 gram vial (NDC 55390-0134-01)
Manufacturing delays

 

Bedford put all inventory on distribution hold in early-July, 2012 pending a new manufacturing-related investigation. Availability of products is updated on the Bedford Laboratories website.

Bedford issued a voluntary recall of 3 lots of cytarabine 1 gram vials in February, 2012. The company determined there was a potential increased risk for lack of sterility with these specific lots. More information can be found online.

Bedford discontinued cytarabine 2 gram presentations in May, 2011 to concentrate on the manufacturing of other products.
APP
1-888-386-1300
100 mg/mL, 20 mL vial (NDC 63323-0120-20)
Shortage resolved APP reports good supply and no further supply issues are anticipated.
Hospira Inc. 1-877-946-7747 20 mg/mL; 50 mL PBP (NDC 61703-303-46), 20 mg/mL; 25 mL (NDC 61703-304-36), 20 mg/mL; 5 mL (NDC 61703-305-38), 100 mg/mL 20 mL (NDC 61703-319-22) Shortage resolved

Hospira reports good supply and no further supply issues are anticipated.

Cyanocobalamin Injection

Updated: 01/25/2013

American Regent/Luitpold
1-800-645-1706
Other 1000 mcg/mL, 1 mL vial (NDC 00517-0031-25), 1000 mcg/mL, 10 mL vial (NDC 00517-0032-25), 1000 mcg/mL, 30 mL vial (NDC 00517-0130-05) temporarily unavailable.
Next delivery mid February 2013.
APP
1-888-386-1300
Increased demand 1000 mcg/mL, 1 mL vial (NDC 63323-0044-01) currently back-ordered. Check wholesalers for inventory.  Next release anticipated late January 2013.

Daunorubicin hydrochloride solution for injection

Updated: 10/25/2012

Teva Pharmaceuticals
1-800-545-8800

5 mg/mL, 4 mL single-dose vial (NDC 00703-5233-13)]

Increased demand

Supply available

Teva has ample supply available.

Bedford Customer Service
1-800-562-4797

5 mg/mL, 4 mL single-dose vial (NDC 55390-0108-10), 10 mL single-dose vial (NDC 55390-0108-01) Cerubidine lyophilized powder for injection, 20 mg single-dose vial, package of 10 (NDC 55390-0281-10)
Manufacturing delays

Discontinuation of the manufacture of the drug.

Denileukin diftitox (ONTAK) Injection

150 mcg/mL, Eisai
2 mL vial (NDC 62856-0603-01)

Updated: 01/24/2013

Eisai
Eisai Medical Services: 1-888-422-4743
Manufacturing issue

For information on Patient Access Program, please visit: http://www.ontak.com/.

Dexamethasone Sodium Phosphate Injection

Updated: 01/15/2013

American Regent/Luitpold
1-800-645-1706
Other American Regent is currently not manufacturing Dexamethasone Sodium Phosphate Injection, USP. 
APP
Customer Service
1-888-386-1300
Increased demand

4 mg/mL, 1 mL single dose vial (NDC 63323-0165-01), 20 mg/5 mL single dose vial (NDC 63323-0165-05), 120 mg/30 mL multiple dose vial (NDC 63323-0165-30), and 10 mg/mL, single dose vial (NDC 63323-0506-01) are available. Check wholesaler inventory.

100 mg/10 mL multiple-dose vial backordered.  Next release expected mid-late March 2013.

Pfizer Injectables
1 800-533-4535
Delay in shipping Unavailable. Estimated Recovery 4/1/2013.

Dexrazoxane Injection (Zinecard)

Updated: 01/15/2013

Mylan Institutional
1-888-258-4199
Increased demand Available from wholesalers
Pfizer Injectables
1-800-533-4535
Other Pfizer Injectables has available vials of 250 mg NDC (0013-8717-62), 500 mg (NDC 0013-8727-89).
Topotarget USA, Inc.
1-973-895-6900
Other

Topotarget USA has worked with the US Food and Drug Administration (FDA) to increase the availability of Totect Kits.  Effective February 6, 2012, the FDA has approved the extension of the expiration date to 36 months for Totect Kits with following batch numbers:

Batch 1914008/W005755/008 expired Nov 2011  (Dear Healthcare Customer Letter 008 PDF - 78KB)

Batch 1925943/W005755/009 expired Dec 2011  (Dear Healthcare Customer Letter 009 PDF - 75KB

Batch 1979183/W005755/010 expired Mar 2012   (Dear Healthcare Customer Letter 010 PDF - 75KB)

Batch 1985218/W005755/011 expired Mar 2012   (Dear Healthcare Customer Letter 011 PDF - 75KB

Topotarget USA, Inc. has recently released additional 129 kits to help fill the back order for this product. The company cannot estimate a release for additional Totect Kits at this time.

DOXIL (doxorubicin HCl liposome injection)

Updated: 01/07/2013

Sun Pharma Global FZE (Caraco Pharmaceutical, U.S. distributor)
1-888-835-2237

(Lipodox (10 ml): NDC 47335-082-50 and Lipodox 50 (25 ml): NDC 47335-083-50)
 

Available

Sun Pharma Global FZE, and its authorized distributor, Caraco Pharmaceutical Laboratories Ltd, in conjunction with the FDA, are initiating a temporary importation of Lipodox (doxorubicin HCL liposomal for injection), into the United States market to address this shortage. Please see the Dear Healthcare Professional Letter (PDF - 65KB) for information about supplies that are now available to help address the current shortage.
Frequently Asked Questions (FAQs) about Sun's Lipodox (doxorubicin HCL liposomal injection) (PDF - 20KB)

Janssen Products, LP (formerly Centocor Ortho Biotech Products, L.P.)
1-800-526-7736

(Doxil 2 mg/mL, Janssen Products, LP
2 mg/mL, 10 mL (20 mg) vial (NDC 59676-0960-01)
Limited supplies available. A manufacturing supplement is under expedited review with FDA

While the manufacturing supplement is under expedited review with the Food and Drug Administration (FDA).  Janssen is coordinating with FDA to release additional supply of DOXIL (doxorubicin HCl liposome injection) under regulatory discretion, that was produced using an alternative manufacturing process.  Please see the Dear Healthcare Professional Letter (PDF - 1MB) for additional information.

See consumer update at
www.doxilsupply.com 

Doxorubicin Solution for Injection

Updated: 01/15/2013

APP
1-888-386-1300
APP Product Availability Information 
Increased demand

APP has available the 2 mg/mL 5 mL vials (NDC 63323-883-05), the 2 mg/mL 10 mL vials (NDC 63323-883-10), the 2 mg/mL 25 mL vials (NDC 63323-0883-30), and the 2 mg/mL 100 mL vials (NDC 63323-0101-61).

No supply issue anticipated.

Teva Pharmaceuticals
1-800-545-8800
Manufacturing delays

Teva has available all presentation of Doxorubicin. Teva is reviewing all orders before release.

No supply issue anticipated.

Bedford
1-800-562-4797
Discontinuation of the manufacture of the drug.

Bedford Laboratories has 10 mg available in limited quantities. Once this supply is depleted, the next estimated release dates are unknown. Other presentations are pending release with release date yet to be determined.

Pfizer Injectables
1-800-533-4535
Pfizer has product available

Pfizer Injectables has available vials of 10mg/5mL (NDC 0069-3030-20), 20mg/10mL (NDC 0069-3031-20), 50mg/25mL (NDC 0069-3032-20), 150mg/75mL (NDC 0069-3033-20), 200mg/100mL (NDC 0069-3034-20).

No supply issue anticipated.

Fluorouracil Shortage (5-FU)

Updated: 10/25/2012
APP Pharmaceuticals
1-888-386-1300
Increased demand

APP has fluorouracil 50 mL vials on back order and the company cannot estimate a release date. APP is allocating the 10, 20, and 100 mL vials.

Teva Pharmaceuticals
1-800-545-8800
Increased demand

Teva has fluorouracil injection 50 mg/mL in 10 mL, 50 mL and 100 mL vials available with ample inventory.

No supply issue anticipated.
Mylan Institutional (formerly Bioniche) Increased demand

Mylan is allocating all luorouracil injection presentations.

Gallium Nitrate (Ganite) Injection

Updated: 04/04/2012

Genta Incorporated
1-888-TO-GENTA)
Discontinuation of the manufacture of the drug. No estimated date of availability.

Leuprolide Acetate Injection

Updated: 01/18/2013

Teva
1-800-545-8800
Requirements related to complying with good manufacturing practices Teva has Leuprolide Injection on backorder.  Teva anticipates product availability in Q213.
Sandoz
1-609-627-8500
Other Product currently unavailable. Manufacturing site availability, we will continue to provide updates as further information becomes available. Estimate available early 2013.
Caraco
313-871-8400
Increased demand On intermittent backorder.

Lidocaine Hydrochloride (Xylocaine) Injection

Updated: 01/23/2013

APP Customer Service: 
1-888-386-1300
Increased demand All lidocaine and Xylocaine presentations are on intermittent back order and will be released as the product becomes available.
Hospira, Inc. Customer Service: 1-877-946-7747 Other Please check with your wholesaler for available inventory. 
Amphastar Pharmaceuticals, Inc. Customer Service: 1-800-423-4136 Increased demand Amphastar is experiencing a product shortage due to an increase in product demand caused by market supply issues.
American Regent/Luitpold
1-800-645-1706
Other Regent/Luitpold is not manufacturing Lidocaine HCl Injection, USP

Leucovorin Calcium Lyophilized Powder for Injection

Updated: 10/25/2012

Bedford Laboratories
Customer Service
1-800-562-4797

Discontinuation of the manufacture of the drug.

 

  • Bedford has all leucovorin calcium on back order and cannot estimate a release date.
  • There is limited supply of the 50 mg, 100 mg, 200 mg, and 350 mg vials. These are available for drop shipment or direct orders after allocation approval.
 
Teva Pharmaceuticals
1-800-545-8800
Manufacturing delays, increased demand
  • Teva has leucovorin calcium lyophilized powder 100 mg and 350 mg vials on back order and the company cannot estimate a release date.
  • Teva has limited supplies of imported leucovorin calcium (calcium folinate solution) 10 mL vials available for drop shipment only.
  • The 30 mL vial supply is depleted and the company estimates release of more product in mid-to-late October, 2012.
 
APP Pharmaceuticals
1-888-386-1300
Increased demand APP has leucovorin lyophilized powder 200 mg and 500 mg vials on intermittent back order and the company is allocating product as it becomes available.

Lorazepam (Ativan) Injection

Updated: 04/22/2013

West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174
Increased demand

West-Ward is anticipating having additional lots of inventory available in the March 2013 timeframe.

Product will be made available as it is released.

Bedford Laboratories Customer Service:
1-800-562-4797
Discontinuation of the manufacture of the drug. Product Discontinued: Bedford currently has all presentations discontinued.
Hospira Inc. Customer Service:
1-877-946-7747
Other

Next delivery mid April
Estimated recovery 2Q 2013

Please check with your wholesaler for available inventory.

Akorn Pharmaceutical:
1-800-932-5676
Available  
Amphastar Pharmaceuticals, Inc./IMS
Customer Service:
1-800-423-4136
Available Amphastar announces the availability of Lorazepam Injection USP, 2 mg/mL, 10 mL vial

Magnesium Sulfate Injection

Updated: 04/22/2013

APP Customer Service:
1-888-386-1300

Increased demand Check wholesalers for inventory.  All other presentations are on intermittent back-order and the company is releasing product as it becomes available.
American Regent/Luitpold
1-800-645-1706
Other American Regent is currently not releasing Magnesium Sulfate Injection.
Hospira, Inc. Customer Service
1-877-946-7747
Shortage of an active ingredient  Please check with your wholesaler for available inventory.

Methotrexate Injection / Methotrexate lyophilized powder for injection

Updated: 10/25/2012

APP Customer Service:
1-888-386-1300
 

Increased demand

Product available.

Please check wholesalers for inventory

Bedford Customer Service:
1-800-562-4797
Manufacturing issue

Discontinuation of the manufacture of the drug.

Hospira, Inc. Customer Service
1-877-946-7747

Other manufacturer shortage/withdrawal

Available

Please check with your wholesaler for all available inventory.

Mylan Institutional
1-888-258-4199
Significant increase in demand

 

  • 2 mL and 10 mL vials on allocation. Please check with your wholesaler for availability.
     
  • 40 mL vial currently unavailable

 

Sandoz Customer Service:
1-609-627-8500
Manufacturing delays
  • Temporarily discontinued the 2 ml vial presentation.
  • Temporarily discontinued the 10 mL vial presentation
  • Experiencing a back order on 40ml vials
 

Teva:
1-800-545-8800

All presentation are available with ample inventory.
  • 25mg/ml; 2mL vial Preservative Free (NDC 00703-3671-03)
  • 25mg/ml; 4mL vial Preservative Free (NDC 00703-3673-01)
     
  • 25mg/ml; 10mL vial Preservative Free (NDC 00703-3675-01)
     
  • 25mg/mL; 40mL vial Preservative Free (NDC 00703-3678-01)
 

Metoclopramide (Reglan) Injection

Updated: 01/18/2013

Hospira Inc. Customer Service:
1-877-946-7747
Increased demand

Next delivery January. Estimated recovery 2Q 2013

Teva Pharmaceuticals
1-800-545-8800
Increased demand Teva has made the decision to re-introduce Metoclopramide to the market.  We expect availability by Q3 2013.

Mitomycin Powder for Injection

Updated: 01/17/2013

Accord Customer Service:
919-941-7879

Bedford Laboratories:
1-800-562-4797

No supply issue anticipated.  

Morphine Sulfate Injection

Updated: 04/22/2013

Hospira Inc. Customer Service: 
1-877-946-7747
Manufacturing delay

Next delivery late April/May
Estimated recovery: 2Q 2013

Please check with your wholesaler for available inventory.

Amphastar Pharmaceuticals Inc.
Customer Service:
1-800-423-4136
Increased demand Amphastar is experiencing a product shortage due to an increase in product demand caused by market supply issues
West-Ward Pharmaceuticals Customer Service:
1-800-631-2174
Increased demand

West-Ward has accelerated production on all Morphine codes and is projecting to have additional inventory available for release in the January – February 2013 timeframe.

Product will be made available as it is released

Morphine Sulfate (Astramorph PF, Duramorph, Infumorph) Injection (Preservative Free)

Updated: 04/22/2013

APP
1-888-386-1300
Astramorph (preservative-free)
Manufacturing delay APP has preservative-free Astramorph 0.5 mg/mL 2 mL ampules, 1 mg/mL 2 mL ampules and 10 mL ampules, and 0.5 mg/mL 10 mL vials on back order with an estimated release date of Q1 2013.
Hospira, Inc.
Customer Service:
1-877-946-7747
Other New preservative-free products to replace preserved products NDC 0409-1762-30, NDC 0409-1258-30, NDC 0409-1260-69, NDC 0409-1261-30, and NDC 0409-1264-31
West-Ward Pharmaceuticals Customer Service:
1-800-631-2174
Increased demand West-Ward is anticipating having product available by the end of March 2013.

Mustargen (mechlorethamine HCl) injection

Updated: 10/25/2012

Lundbeck Inc.
Customer service number:
1-888-514-5204

10 mg/vial (NDC 67386-911-51
Product Available
  • Product can be ordered using the NDC number 67386-91151 or looking Mustargen up in your wholesaler's system.
  • Additional Information  
 

Ondansetron (Zofran) Injection 2 mg/mL

Updated: 01/18/2013

APP
1-888-386-1300
Increased demand APP currently has both presentations of Ondansetron available. Please check wholesalers for inventory.

Bedford
Customer Service:
1-800-562-4797

20 mL vial (NDC 55390-0121-01)

Discontinuation of the manufacture of the drug.

Bedford has ondansetron 2 mg/mL 20 mL vials on back order and the company cannot estimate a release date. Bedford Laboratories has multiple products affected by this temporary suspension of manufacturing. Bedford will have the affected, as well as the available products, listed on their website and are updating this information as it changes. The company voluntarily suspended all manufacturing and distribution in mid-November, 2011 on a temporary basis for maintenance and requalification of equipment. Product will become available in stages as production resumes.

Bedford discontinued the following products:
2 mL vials, packages of 10 (NDC 55390-0121-10)
2 mL Novaplus vials, packages of 10 (NDC 55390-0307-10)
20 mL Novaplus vials, packages of 1 (NDC 55390-0307-01)

Caraco
313-871-8400
Discontinuation of the manufacture of the drug. Caraco temporarily discontinued ondansetron injection
Hospira, Inc.
Customer Service:
1-877-946-7747
Increased demand Next delivery mid January. Estimated recovery 3Q 2013.
West-Ward (formerly Baxter products)

Customer Service:
1-800-631-2174
(Formerly a Baxter Product)  

Increased demand West-Ward has increased production and is anticipating having additional product available in the January - February 2013 timeframe.
Product will be made available as it is released.
Teva
1-800-545-8800
Increased demand Teva has limited inventory
GlaxoSmithKline
Customer Service:
1-888-825-5249
Increased demand GlaxoSmithKline has the following available: 20 mL vial (NDC 00173-0442-00). GlaxoSmithKline has discontinued Zofran 2 mL vials

Wockhardt

Customer Service:
1-800-346-6854

Increased demand Wockhardt has existing inventories and no backorder presently 
Pfizer
1-800-533-4535
Delay in shipping of the drug Limited supply.
Sagent Pharmaceuticals 1-866-625-1618 Increased demand Available.

Ondansetron Injection 32 mg/50 mL premixed bags

Updated: 01/18/2013

Claris Other Pending information
Sagent Pharmaceuticals
1-866-625-1618
Discontinuation of the manufacture of the drug. Sagent has discontinued their ondansetron premixed bags.
Teva Pharmaceuticals
1-800-545-8800
Discontinuation of the manufacture of the drug. Teva has voluntarily withdrawn their application for this product.
Hospira, Inc.
Customer Service:
1-877-946-7747
Discontinuation of the manufacture of the drug Product discontinued due to FDA Drug Safety Communication
Baxter
Customer Service:
1-888-229-0001
Discontinuation of the manufacture of the drug New safety information communicated in the  FDA Drug Safety Communication issued 06/29/2012

Peginterferon Alpha-2A (Pegasys) Injection-Prefilled Syringes

Updated: 09/24/2013

Genentech Resource Center:
1-877-436-3683
Increased demand, manufacturing delays Potential limited availability of the PFS form of 180 mcg/mL Pegasys. The firm anticipates that the potential shortage of the PFS will resolve by end of June 2013.

Pentamidine isethionate inhalant (NebuPent)

Updated: 01/07/2013

APP
1-888-386-1300
Shortage of an active ingredient Available.  Check wholesalers for inventory.

Pentostatin for Injection (Nipent)

Updated: 01/17/2013

Hospira Inc.
Customer Service:
1-877-946-7747

Bedford Customer Service
1-800-562-4797 

No supply issue anticipated.  

Potassium Chloride Injection 2 mEq/mL

Updated: 04/22/2013

APP Pharmaceuticals
1-888-386-1300
Increased demand APP is currently back-ordered on all presentations of potassium chloride and is releasing product intermittently.
B. Braun Medical Inc.
Customer Service:
1-800-227-2862
Available  
Baxter
Customer Service:
1-800-ANA-DRUG
(1-800-262-3784)
Increased demand, available  
Hospira, Inc.
Customer Service:
1-877-946-7747
Increased demand Next delivery September 2013. Please check with your wholesaler for available inventory.

Potassium Phosphate Injection

Updated: 01/23/2013

Hospira Inc.
(1-877-946-7747)
Other Next delivery end February  Estimated recovery 2Q 2013
American Regent/Luitpold
1-800-645-1706
Other

American Regent//Luitpold is not manufacturing the 5 mL vials.
American Regent//Luitpold is not manufacturing the 15 mL vials.
American Regent//Luitpold is not releasing the 50 mL vials

Prochlorperazine (Compazine) Edisylate Injection

Updated: 01/30/2012

Bedford Customer Service
1-800-562-4797
Manufacturing issue

Bedford has both prochlorperazine 5 mg/mL injection presentations on back order and the company cannot estimate a release date. The 2 mL vials are pending release while the 10 mL vials will not be manufactured until capacity permits.

Sodium Bicarbonate Injection
Updated: 04/22/2013

Amphastar Pharmaceuticals Inc.
Customer Service:
1-800-423-4136

8.4%, 50mL Luer-Jet Prefilled Syringe
NDC 76329-3352-1
(old NDC 0548-3352-00)

Increase in product demand caused by market supply issues.

Amphastar will regularly release products.
Amphastar is experiencing a product shortage due to an increase in product demand caused by market supply issues.

APP
1-888-386-1300

4.2% 2.5 mEq, 5 mL (NDC 63323-0026-05)

Demand increase for the drug.

Next delivery expected January 2013. Please check wholesalers for inventory.

Hospira, Inc.
Customer Service:
1-877-946-7747

4%; 5 mL vial (NDC 0409-6609-02) (Available )

0.5 mEq/mL; 10 mL Abboject (NDC 0409-5534-34) (Next delivery October Estimated recovery 1Q 2013)

0.9 mEq/mL (Next delivery October Estimated)

Demand increase for the drug

Please check with your wholesaler for available inventory.

Shortage per Manufacturer:
Other manufacturer shortage/withdrawal
Sagent Pharmaceuticals, Inc.
1-866-625-1618
Other Sagent Pharmaceuticals, Inc. (Sagent) is coordinating with the Food and Drug Administration (FDA) to increase the availability of Sodium Bicarbonate Injection. In cooperation with the FDA, Sagent has initiated temporary importation of a non FDA approved 8.4% Sodium Bicarbonate Injection (1 mEq/mL) from Phebra Pty Ltd (Phebra), Australia into the US market.
Please see the Dear Healthcare Professional Letter (PDF - 129KB) (updated) for information about supplies that are available to help address the current shortage.

Thiotepa for Injection, Bedford
15 mg/mL vial (NDC 55390-0030-10)

Updated: 10/25/2012

Bedford Laboratories Customer Service 1-800-562-4797

15 mg/mL vial (NDC 55390-0030-10)

Discontinuation of the manufacture of the drug.

Bedford Laboratories has 15mg available in limited quantities.  Once this supply is depleted, the next estimated release dates are unknown.

Adienne
Guglielmo Bianchi, Customer Service
Tel: + 41.789.451.694
Fax: + 41.919.211.978

 Other Adienne, in conjunction with the FDA, is initiating a temporary importation of Thiotepa for injection, to the United States market. Please see the Dear Healthcare Professional Letter (PDF - 87KB)40 for information about emergency supplies that are now available to help address the shortage.

Vinblastine Sulfate Injection

Updated: 01/07/2013

APP
1-888-386-1300
Increased demand Check wholesalers for inventory.

Vitamin K1 (Phytonadione) Injection, Emulsion

Updated: 01/17/2013
 

Hospira, Inc.
Customer Service:
1-877-946-7747

Amphastar Pharmaceuticals, Inc./IMS
1-800-423-4136

No supply issue anticipated.  

Additional Resources

ASH's Comments to Congress and the U.S. Food and Drug Administration On How to Address Drug Shortages and Strengthen Current Efforts

Media Coverage of Drug Shortages

back to top